Cresco Labs Inc. (CSE: CL)
Canada
· Delayed Price · Currency is CAD 2.090
+0.050 (2.45%)
Nov 1, 2024, 10:14 AM EDT
Cresco Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 734.82 | 756.06 | 824.93 | 805.68 | 463.08 | 124.19 | Upgrade
|
| Revenue Growth (YoY) | -6.55% | -8.35% | 2.39% | 73.98% | 272.87% | 200.46% | Upgrade
|
| Cost of Revenue | 370.67 | 408.52 | 430.2 | 375.9 | 252.63 | 52.58 | Upgrade
|
| Gross Profit | 364.15 | 347.54 | 394.73 | 429.79 | 210.45 | 71.61 | Upgrade
|
| Selling, General & Admin | 227.29 | 259.81 | 309.86 | 276 | 198.65 | 91.52 | Upgrade
|
| Other Operating Expenses | - | - | - | 16 | 13.17 | - | Upgrade
|
| Operating Expenses | 253.82 | 284.34 | 330.5 | 313.6 | 228.95 | 95.74 | Upgrade
|
| Operating Income | 110.33 | 63.19 | 64.23 | 116.18 | -18.5 | -24.12 | Upgrade
|
| Interest Expense | -56.7 | -62.97 | -58.52 | -52.15 | -32.64 | -9.46 | Upgrade
|
| Interest & Investment Income | 2.72 | 2.15 | 0.68 | 0.94 | 1.41 | 1.68 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -1.2 | -1.18 | -0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.39 | -0.3 | 0.93 | -1.23 | -1.42 | 0.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -59.78 | 0.42 | -0.7 | 26.91 | -5.61 | -3.76 | Upgrade
|
| EBT Excluding Unusual Items | -3.04 | 2.5 | 6.62 | 89.46 | -57.93 | -35.31 | Upgrade
|
| Merger & Restructuring Charges | 0.13 | - | -5.47 | -27.64 | -3.75 | -3.87 | Upgrade
|
| Impairment of Goodwill | -50.86 | -50.86 | -117.02 | -215.55 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | -0.41 | -4.59 | 1.29 | -0.16 | -1.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.06 | 0.76 | 12.31 | -1.11 | -0.13 | -7.1 | Upgrade
|
| Asset Writedown | -78.66 | -100.16 | -23.63 | -90.34 | -1.22 | - | Upgrade
|
| Other Unusual Items | - | 1.26 | 4.88 | -12.83 | -0.98 | -3.05 | Upgrade
|
| Pretax Income | -131.37 | -146.9 | -126.91 | -256.73 | -64.17 | -50.84 | Upgrade
|
| Income Tax Expense | 30.45 | 32.95 | 88.94 | 40.11 | 28.6 | 14.46 | Upgrade
|
| Earnings From Continuing Operations | -161.81 | -179.85 | -215.84 | -296.83 | -92.77 | -65.3 | Upgrade
|
| Minority Interest in Earnings | -10.65 | 4.33 | 3.8 | -22.76 | -9.39 | 22.1 | Upgrade
|
| Net Income | -172.46 | -175.52 | -212.05 | -319.6 | -102.16 | -43.2 | Upgrade
|
| Net Income to Common | -172.46 | -175.52 | -212.05 | -319.6 | -102.16 | -43.2 | Upgrade
|
| Shares Outstanding (Basic) | 341 | 324 | 298 | 262 | 210 | 118 | Upgrade
|
| Shares Outstanding (Diluted) | 341 | 324 | 298 | 262 | 210 | 118 | Upgrade
|
| Shares Change (YoY) | 11.58% | 8.61% | 13.66% | 24.64% | 77.88% | 99.38% | Upgrade
|
| EPS (Basic) | -0.51 | -0.54 | -0.71 | -1.22 | -0.49 | -0.37 | Upgrade
|
| EPS (Diluted) | -0.51 | -0.54 | -0.71 | -1.22 | -0.49 | -0.37 | Upgrade
|
| Free Cash Flow | 63.47 | 3.18 | -64.29 | -79.39 | -95 | -116.86 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.01 | -0.22 | -0.30 | -0.45 | -0.99 | Upgrade
|
| Gross Margin | 49.56% | 45.97% | 47.85% | 53.34% | 45.45% | 57.66% | Upgrade
|
| Operating Margin | 15.01% | 8.36% | 7.79% | 14.42% | -3.99% | -19.42% | Upgrade
|
| Profit Margin | -23.47% | -23.22% | -25.70% | -39.67% | -22.06% | -34.79% | Upgrade
|
| Free Cash Flow Margin | 8.64% | 0.42% | -7.79% | -9.85% | -20.52% | -94.10% | Upgrade
|
| EBITDA | 176.14 | 125.71 | 116.16 | 154.82 | 13.29 | -16.31 | Upgrade
|
| EBITDA Margin | 23.97% | 16.63% | 14.08% | 19.22% | 2.87% | -13.14% | Upgrade
|
| D&A For EBITDA | 65.81 | 62.51 | 51.93 | 38.64 | 31.79 | 7.81 | Upgrade
|
| EBIT | 110.33 | 63.19 | 64.23 | 116.18 | -18.5 | -24.12 | Upgrade
|
| EBIT Margin | 15.01% | 8.36% | 7.79% | 14.42% | -3.99% | -19.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.